A new Israeli scientific study has shown that the use of medicinal cannabis in children under the 18 who are diagnosed with autism spectrum disorders (ASD) can alleviate common and common symptoms such as seizures, disruptive behavior, depression and restlessness.
ASD is a set of neurological disorders that affect communication, behavior and social skills and for which there is no specific treatment. According to the World Health Organization, it affects 1 in 160 children worldwide, and over the past three decades, the number of children diagnosed has risen three-fold, the study said. Interventions often focus on intensive behavioral therapies that require a high level of care.
The Israeli study was conducted by researchers from Ben-Gurion University of the Negev (BGU) and Soroka University Medical Center in Beersheva. Among them was Professor Raphael Mechoulam, the acclaimed organic chemist who in 1964 was the first to identify cannabis's THC compound, the chemical known for causing the "high feeling" associated with cannabis use. Mechoulam is regarded as the foundation for scientific research into cannabis and its use in modern medicine.
Read the full article Nocamels.com (source), photo Demi Pradolin.